Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE
Chief Executive
Dear ContractorCPNI received notification yesterday afternoon of the funding arrangements that SPPG will be putting in place for adherence support to patients from 1 April 2023. Contractors will be notified by SPPG later today and advised of the new arrangements being applied by SPPG from 1 April 2023.
There has been no discussion or negotiation with CPNI on the changes to the adherence funding arrangements, which are a significant departure from those previously used, and therefore the new arrangements represent an imposition by SPPG and DoH(NI) from 1 April 2023.
CPNI is disappointed at the approach that is being taken by SPPG and DoH(NI) and has serious concerns about the implications this will have going forward.
CPNI Board will be meeting next week to discuss this and other relevant matters as a matter of priority and will keep contractors fully informed.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The third update of concessionary prices were granted today for March 2023:
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
As you will be aware, CPNI has been engaging with NICPLD on the Experiential Learning (EL) Programme over recent months and keeping contractors updated accordingly. Community pharmacy as a sector is supportive of EL and particularly welcomes the opportunity to encourage our students to pursue a career in community pharmacy. In order to do that, CPNI believes students need to have a positive EL placement with adequate support in a conducive environment. The pressures currently facing the community pharmacy network, in terms of workforce, workload and funding, are of such magnitude that CPNI would suggest that contractors consider their own situations objectively to decide if it will be feasible for their pharmacy to participate, and whether it is the right time for students to experience the harsh reality of community pharmacy. CPNI will remain supportive of the EL programme and engage with those involved, but we have to ensure that the programme is providing the right foundation for students and contractors to build the future of community pharmacy upon. Unfortunately, that is not currently the status and without significant investment the community pharmacy service is at real risk.
CPNI are aware that NICPLD are seeking availability from contractors for the dates they would be able to host EL placements and also seeking further providers to register with NICPLD. We also understand that contractors may previously have registered their interest in becoming an EL provider.
Given discussions at the most recent contractor meeting, contractors may consider deferring giving any further commitment at this time, including accepting any placements or returning any contracts/declarations, until such time that community pharmacy is equipped to offer students the experience of the sector they deserve.
Please do not hesitate to contact the CPNI office or your local CPNI Director if you have any further queries.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please see attached correspondence from the Department of Health outlining the plans for Phase 2 of the SRP claims process.
While the vast majority of eligible individuals captured in Phase 1 of the process, which was co-ordinated by the Health & Social Care Board (HSCB) on behalf of the DoH during 2021/22. Phase 2 guidance documentation and claim template have been developed to support the implementation of the SRP for Community Pharmacy.
If contractors identify there are further eligible individuals you need to claim for in the SRP Phase 2 process, please follow the guidance attached and complete the Phase 2 claim template for any remaining eligible individuals and return to SPPG dedicated email addresses available HERE. If you have assessed that you do not need to make an SRP Phase 2 claim return, please confirm this by email, quoting your Practice number on the subject line of the email and also adding “Nil Return” to the subject line of the email.
When the supporting information has been received and your claim has been checked/validated, SPPG will confirm the value of the SRP reimbursement to you and the date the payment will be processed. If you have any queries, please direct these by email to the StaffRecognitionPaymentQueries@hscni.net email address in the first instance.
Care home residents are considered to be a priority group for spring COVID-19 booster vaccinations. PHA has arranged that those community pharmacies vaccinating the care homes will receive priority in vaccine deliveries, if vaccines are ordered this week.
For the purposes of planning pharmacies will have paired with the care homes they plan to vaccinate and are asked to calculate approximate numbers of vaccines needed to complete the care home population. Pharmacies are also asked to allow an overage to facilitate walk in patients, and to expect vaccine delivery from Movianto in 3-5 days depending on weekends and Easter will restrict delivery options to pharmacies.
Contractors are asked to order the total number of vaccines needed to complete the care homes. If orders are not placed this week this will impact on vaccine deliveries and will delay the onset of clinics in care homes post Easter. It is worth noting the pack size of Comirnaty Original/Omicron BA.4-5 is 60 (6x10dose vials) the vaccine expiry is 10 weeks from date of thaw.
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
